Quarterly report pursuant to Section 13 or 15(d)

ACQUISITION - Narrative (Details)

v3.21.2
ACQUISITION - Narrative (Details) - Sentry Neuromonitoring, LLC
 9 Months Ended
Apr. 30, 2021
USD ($)
installment
item
shares
Sep. 30, 2021
USD ($)
Business Acquisition [Line Items]    
Cash consideration $ 1,125,000  
Cash consideration, at closing 153,125  
Cash consideration, within 30 days 153,125  
Cash consideration, in thirty-six equal monthly installments (including interest) $ 818,750  
Number of monthly installments | installment 36  
Value of common stock issuable $ 1,625,000  
Common stock issuable | shares 237,226  
Held in escrow, Value $ 650,000  
Held in escrow, Shares | shares 94,891  
Common stock lock up period 12 months  
Receivable bonus payable $ 250,000,000  
Threshold amount in account receivable to pay receivable bonus $ 3,000,001,000  
Number of payments in which receivable bonus is paid | item 3  
Receivable bonus payable on 30th day $ 100,000  
Receivable bonus payable on 60th day 100,000  
Receivable bonus payable on 90th day 50,000  
Founders bonus payable 25,000  
Minimum annual base salary 175,000  
Annual variable compensation bonus 50,000  
Kenneth Sly    
Business Acquisition [Line Items]    
Founders bonus payable $ 50,000  
Maximum    
Business Acquisition [Line Items]    
Reimbursement of expenses to seller   $ 50,000